- Home
- FRPH vs TRDA Comparison
FRPH vs TRDA Comparison
Compare FRPH & TRDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FRPH
- TRDA
- Stock Information
- Founded
- FRPH 1986
- TRDA 2016
- Country
- FRPH United States
- TRDA United States
- Employees
- FRPH N/A
- TRDA N/A
- Industry
- FRPH Real Estate
- TRDA Biotechnology: Pharmaceutical Preparations
- Sector
- FRPH Finance
- TRDA Health Care
- Exchange
- FRPH Nasdaq
- TRDA Nasdaq
- Market Cap
- FRPH 576.6M
- TRDA 502.9M
- IPO Year
- FRPH N/A
- TRDA 2021
- Fundamental
- Price
- FRPH $30.54
- TRDA $13.58
- Analyst Decision
- FRPH
- TRDA Strong Buy
- Analyst Count
- FRPH 0
- TRDA 3
- Target Price
- FRPH N/A
- TRDA $25.67
- AVG Volume (30 Days)
- FRPH 27.0K
- TRDA 115.5K
- Earning Date
- FRPH 03-05-2025
- TRDA 03-12-2025
- Dividend Yield
- FRPH N/A
- TRDA N/A
- EPS Growth
- FRPH 45.62
- TRDA N/A
- EPS
- FRPH 0.40
- TRDA 1.55
- Revenue
- FRPH $31,414,000.00
- TRDA $215,232,000.00
- Revenue This Year
- FRPH N/A
- TRDA $47.45
- Revenue Next Year
- FRPH N/A
- TRDA N/A
- P/E Ratio
- FRPH $76.97
- TRDA $8.74
- Revenue Growth
- FRPH 4.04
- TRDA 146.92
- 52 Week Low
- FRPH $26.99
- TRDA $11.35
- 52 Week High
- FRPH $33.00
- TRDA $21.79
- Technical
- Relative Strength Index (RSI)
- FRPH 54.78
- TRDA 38.99
- Support Level
- FRPH $30.50
- TRDA $12.53
- Resistance Level
- FRPH $31.39
- TRDA $13.84
- Average True Range (ATR)
- FRPH 0.59
- TRDA 0.57
- MACD
- FRPH 0.11
- TRDA 0.21
- Stochastic Oscillator
- FRPH 69.65
- TRDA 81.32
About FRPH FRP Holdings Inc.
FRP Holdings Inc is a holding company engaged in various real estate businesses. The company's business segments are Leasing and management of commercial properties owned by the company (the Industrial/Commercial Segment); Leasing and management of mining royalty land owned by the company (the Mining Royalty Lands Segment); real property acquisition, entitlement, development and construction for apartment, retail, warehouse, and office buildings either alone or through joint ventures (the Development Segment); ownership, leasing and management of buildings through joint ventures (the Multifamily Segment).
About TRDA Entrada Therapeutics Inc.
Entrada Therapeutics Inc clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient delivery of a wide range of therapeutics into a variety of organs and tissues, resulting in an improved therapeutic index. Its pipeline includes solutions for Neuromuscular Disease, Beyond Neuromuscular, and Platform Expansion.